Gary Bridger
45Patents
20h-index
56Co-inventors
88Inventor score
Filing activity: Dec 16, 1992 → Feb 8, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5817807A | Antiviral compounds | Chemistry; Metallurgy | 80 | Expired |
| US5583131A | Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity | Chemistry; Metallurgy | 76 | Expired |
| US5698546A | Cyclic polyamines | Human Necessities | 69 | Expired |
| US6365583B1 | Methods to enhance white blood cell count | Chemistry; Metallurgy | 65 | Expired |
| US7169750B2 | Methods to mobilize progenitor/stem cells | Human Necessities | 61 | Expired |
| US7291631B2 | CXCR4 chemokine receptor binding compounds | Chemistry; Metallurgy | 42 | Expired |
| US5350837A | Complexes with .sup.99m Tc suitable for radiolabelling monoclonal antibodies or other macro molecules | Human Necessities | 40 | Expired |
| US6506770B1 | Antiviral compounds | Chemistry; Metallurgy | 39 | Expired |
| US6987102B2 | Methods to mobilize progenitor/stem cells | Human Necessities | 32 | Expired |
| US6750348B1 | Chemokine receptor binding heterocyclic compounds | Chemistry; Metallurgy | 28 | Expired |
| US6835731B2 | Chemokine receptor binding heterocyclic compounds | Chemistry; Metallurgy | 27 | Expired |
| US6864265B2 | Chemokine receptor binding heterocyclic compounds | Chemistry; Metallurgy | 27 | Expired |
| US7354934B2 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | Chemistry; Metallurgy | 25 | Expired |
| US7091217B2 | Chemokine receptor binding heterocyclic compounds | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7935692B2 | Methods to mobilize progenitor/stem cells | Human Necessities | 23 | Active |
| US6825351B2 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | Chemistry; Metallurgy | 22 | Expired |
| US7354932B2 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7863293B2 | CXCR4 chemokine receptor binding compounds | Chemistry; Metallurgy | 21 | Active |
| US7897590B2 | Methods to mobilize progenitor/stem cells | Human Necessities | 21 | Active |
| US6734191B2 | Chemokine receptor binding heterocyclic compounds | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5792444A | Labeled chemotactic peptides to image focal sites of infection or inflammation | Emerging Cross-Sectional Technologies | 20 | Expired |
| US7414065B2 | Methods to modulate conditions mediated by the CXCR4 receptor | Chemistry; Metallurgy | 19 | Expired |
| US7709486B2 | CXCR4 antagonists | Chemistry; Metallurgy | 19 | Active |
| US6756391B2 | Antiviral compounds | Chemistry; Metallurgy | 19 | Expired |
| US7160872B2 | Methods to treat conditions mediated by chemokine receptors | Chemistry; Metallurgy | 19 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.